Browsing: Form

Children and adults living with a rare condition that causes rapid, uncontrollable weight gain now have a new treatment option following the U.S. Food and Drug Administration’s approval of setmelanotide, based on results from the phase 3 TRANSCEND clinical trial, published in The New England Journal of Medicine